추가 설명:
Microneedle technology represents an advanced form of transdermal drug delivery, using micro-sized needles (typically under 1mm long) to carry drugs past the stratum corneum. CLOPAM is Daewoong Therapeutics' proprietary, patented manufacturing process that ensures efficient delivery and consistently high-quality microneedle patches, offering high bioavailability and bioequivalence, broad applicability, and a safe, simple alternative to injectables.
평가 & 댓글 남기기